Drug Approval | August 31, 2023
Lupin receives USFDA approval for Pirfenidone Capsules
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
This product will be manufactured at Lupin's Pithampur facility in India
The company has entered into a three-year Deferred Prosecution Agreement
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Bromfenac Ophthalmic Solution 0.09% (RLD Bromday) had estimated annual sales of USD 11 million in the U.S. (IQVIA MAT June 2023).
Need to harmonize traditional and modern medicine to combat alarming health problems
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Subscribe To Our Newsletter & Stay Updated
